Home E-Weekly October 10, 2017

News & Notes

Published: October 9, 2017

  • New treatment option for central sleep apnea The FDA has approved an implantable device designed to treat moderate to severe central sleep apnea. The RemedÄ“ System stimulates a nerve in the chest that sends signals to the diaphragm to stimulate breathing. It is not intended to treat obstructive sleep apnea.
  • Improve patient hand-offs The Joint Commission has issued a Sentinel Event Alert aimed at improving communication among healthcare providers during transitions of care. The alert provides tips for handling hand-offs seamlessly, including not relying solely on electronic communication, sharing critical information to the new healthcare provider at one time and using standardized communication tools.
  • Longer anesthesia, more complications The longer patients are under anesthesia during head and neck surgery, the more likely they are to suffer complications, including post-op blood transfusion, according to a study in JAMA Facial Plastic Surgery. These study's authors say surgical teams need to focus on perioperative and nonsurgical factors that may extend anesthesia time and practices that promote intraoperative efficiency.
New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Study Finds Psychosis Drug Amisulpride Reduces Nausea and Vomiting

Small doses of amisulpride, a drug used to manage psychosis, may prevent PONV when given with standard anti-nausea treatment, say researchers.

News & Notes

News & Notes